boringli surpris solid
lift ep estimate post solid though rel in-lin
result unlik recent qtr gener clean incl in-lin org sale
better gm drove ep beat vs street close
watch juli adj sale updat good price action
nov allevi gm concern ntm ev/ebitda share
appropri hist average vs peer maintain buy pt
solid rel line vs consensu org sale growth
rel line vs street gm better vs drive oi beat
ep penni ahead consensu us growth solid organ though
fell short expect vs co experienc
inventori de-stock particularli china could meet demand hot
summer europ
juli gross sale updat like modestli ahead expect management disclos
fx-neutral sale growth juli estimate street yoy fx neutral adjust
extra sell day model org sale unchang follow qtr
believ top-line stori remain intact includ compani
cycl inventori headwind china continu enter new market
takeaway conf call price co plan take price
increas us monster portfolio novemb strateg brand portfolio
januari co explor price action intern though note
share leader mani market would lead w/ price ii china/india
affect profit loss launch nation india end year affect
inventori de-stock china iii mutant co plan de-emphasize brand
us iv gm price help off-set commod increas though co
continu neg affect product/geographic/brand mix
remain top larg cap growth idea lift est pt post solid
edg ep est follow solid qtr though sale growth estimate
unchang buy rate predic strong sale growth
compound-annual-growth-rate us inflect intenational market share gain strong ii valuat
ev/ebitda attract appropri hist premium peer el/stz ko/p/ep
iii strateg option ko acquir remain o/ share drive
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
success us innov could repres upsid
regulatori risk seemingli abat time
compani may face neg geograph product mix
near-to-intermedi term
intent potenti increas stake
forecast organ sale growth
includ approxim growth us
oper margin declin bp larg
gross margin weak expand bp
ulfcf ev/ebitda ebitda
bp us/intl volum upsid
bp om upsid leverag intern
ko decid acquir busi outright current
own outstand share
ev/ebitda strateg multipl ntm
ebitda
volum downsid bp us/intl slow
top-line de-lever result bp om downsid
weight ntm ev/ulfcf
ulfcf ev/ebitda ebitda
page
pleas see import disclosur inform page report
street better om bp vs
street drive oi beat
ep penni better vs
link relev research
juli click
click
top larg cap growth idea lift estimate us survey sharehold meet
june click
click
januari click
broaden base favor survey result support us outlook lift pt
novemb click
page
pleas see import disclosur inform page report
actualjef estconsensu million except ex-stock base distribut base oper item ebitda exclud incom bpssg bpsebitda bpsoper bp
thesi chart
chart street sales/ebitda forecast call
cagr appear somewhat conserv
profit vs estim
bull case suggest mid-teen growth
chart forecast organ sale growth
includ us mix growth
intenational mix growth
chart estim high opportun market
current compris mnst sale drive
compani growth
chart believ deserv trade signific
premium stapl peer given superior growth
profil higher margin lower capit requir
chart appropri trade slightli
histor averag premium el/stz sinc ko deal
page
factset jefferi note invest announc
august
pleas see import disclosur inform page report
flex upsid downsid scenario attract risk/reward
chart summar price target forecast upsid downsid scenario
mnst stock base ntm estim util ev/ulfcf
ev/ebitda methodolog flex upsid downsid scenario rel
ntm forecast unlev ebitda see
attract risk/reward mnst share current level target scenario offer
tsr vs tsr downsid scenario tsr upsid scenario
chart upsid downsid scenario
jefferi note base pt forward estim one year
page
pleas see import disclosur inform page report
base ntm forecastsblendedstock scenariosunlev multiplepriceweightebitdamultiplepriceweightstock scenariostoplin acceler upsid margin ko buy ev/ebitdau remain stabl intern expans progress well deserv trade premium staplestoplin deceler de-lever drive margin downsid de-rates- forecast approxim compar organ sale growth om declin bp larg due gm weak expand bp pt base wtd ev/ul ev/ebitda impli ev/ebitda downside- top-line volum downsid bp slow categori sales- top-line de-lever result bp om downside- stock de-rat ev/ul ev/ebitda impli ev/ebitda ev/unlev methodologykey valu driversupside- bp sale upsid bp om upsid oper leverage/improv intern margins- ko acquir ev/ebitda high end consum stapl multiplesev/ebitda methodolog
trade attract level given
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
page
pleas see import disclosur inform page report
